BioCentury
ARTICLE | Clinical News

Modiodal modafinil regulatory update

December 5, 2011 8:00 AM UTC

Mitsubishi and Alfresa said Japan approved Modiodal modafinil for excessive diurnal sleepiness accompanied by obstructive sleep apnea (OSA) syndrome in patients under treatment for airway obstruction ...